Is increased "stay away from bed" time associated with improved clinical rehabilitation outcomes in Japanese rehabilitation hospitals? A prospective observational study and clinical practice.


Journal

Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995

Informations de publication

Date de publication:
May 2020
Historique:
received: 13 03 2019
accepted: 04 07 2019
pubmed: 22 7 2019
medline: 14 8 2020
entrez: 22 7 2019
Statut: ppublish

Résumé

A comprehensive team approach for increasing stay away from bed time (SaB-time) called CASaB was conducted at multiple rehabilitation hospitals. The aim of the present study was to investigate the association between SaB-time and clinical rehabilitation outcomes (CROs) before introducing CASaB (observational phase), and comparing CROs before and after CASaB (CASaB phase). This prospective observational study included patients who were admitted to nine rehabilitation hospitals, with complete data. The final analysis included 197/229 patients in the observation phase, and 229/256 patients in the CASaB phase. We first tested whether SaB-time was positively associated with CROs in an observational study, then compared CROs before and after CASaB. In the observation phase, longer SaB-time was significantly associated with greater rehabilitation efficiency (REy) after adjusting for confounders (standardized β = 0.20, p = 0.007). In a comparison of CROs before and after CASaB, the length of hospital stay during the CASaB phase was significantly shorter than during the observational phase (61.5, 57.6-65.4 days vs 75.6, 71.4-79.9 days, p < 0.001), and the REy after CASaB was significantly greater than that before the CASaB (0.38, 0.33-0.42/day vs 0.28, 0.25-0.33/day, p = 0.006). The current results suggest that increasing SaB-time may help the recovery of functional abilities, particularly for patients in rehabilitation hospitals. The CASaB provides a method for improving the recovery efficiency of patients in rehabilitation hospitals.

Sections du résumé

BACKGROUND BACKGROUND
A comprehensive team approach for increasing stay away from bed time (SaB-time) called CASaB was conducted at multiple rehabilitation hospitals.
AIMS OBJECTIVE
The aim of the present study was to investigate the association between SaB-time and clinical rehabilitation outcomes (CROs) before introducing CASaB (observational phase), and comparing CROs before and after CASaB (CASaB phase).
METHODS METHODS
This prospective observational study included patients who were admitted to nine rehabilitation hospitals, with complete data. The final analysis included 197/229 patients in the observation phase, and 229/256 patients in the CASaB phase. We first tested whether SaB-time was positively associated with CROs in an observational study, then compared CROs before and after CASaB.
RESULTS RESULTS
In the observation phase, longer SaB-time was significantly associated with greater rehabilitation efficiency (REy) after adjusting for confounders (standardized β = 0.20, p = 0.007). In a comparison of CROs before and after CASaB, the length of hospital stay during the CASaB phase was significantly shorter than during the observational phase (61.5, 57.6-65.4 days vs 75.6, 71.4-79.9 days, p < 0.001), and the REy after CASaB was significantly greater than that before the CASaB (0.38, 0.33-0.42/day vs 0.28, 0.25-0.33/day, p = 0.006).
DISCUSSION CONCLUSIONS
The current results suggest that increasing SaB-time may help the recovery of functional abilities, particularly for patients in rehabilitation hospitals.
CONCLUSIONS CONCLUSIONS
The CASaB provides a method for improving the recovery efficiency of patients in rehabilitation hospitals.

Identifiants

pubmed: 31327123
doi: 10.1007/s40520-019-01269-5
pii: 10.1007/s40520-019-01269-5
pmc: PMC7190592
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

913-920

Références

J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):e305-12
pubmed: 24529353
Am J Nurs. 2006 Jan;106(1):58-67, quiz 67-8
pubmed: 16481783
Cochrane Database Syst Rev. 2018 Jul 27;7:CD012543
pubmed: 30051462
Geriatr Nurs. 2004 Jul-Aug;25(4):212-7
pubmed: 15311196
Arch Phys Med Rehabil. 2017 Mar;98(3):434-441
pubmed: 27633938
J Rehabil Res Dev. 2008;45(4):551-8
pubmed: 18712640
J Am Geriatr Soc. 2011 Jan;59(1):91-5
pubmed: 21158744
J Rehabil Med. 2016 Mar;48(3):280-6
pubmed: 26843147
Arch Intern Med. 2006 Apr 10;166(7):766-71
pubmed: 16606814
J Hosp Med. 2006 Sep;1(5):277-84
pubmed: 17219513
Cochrane Database Syst Rev. 2009 Oct 07;(4):CD007125
pubmed: 19821396
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
BMJ Open. 2013 Sep 24;3(9):e003483
pubmed: 24068767
Clin Nutr. 2018 Dec;37(6 Pt A):2022-2028
pubmed: 28987469
Acta Anaesthesiol Scand. 2008 Mar;52(3):332-7
pubmed: 18269385
J Rehabil Med. 2014 Mar;46(3):277-82
pubmed: 24213734
J Neurol Phys Ther. 2015 Jul;39(3):166-71
pubmed: 26035120
Cerebrovasc Dis. 2005;20(4):258-63
pubmed: 16123546
J Gerontol A Biol Sci Med Sci. 1998 Jul;53(4):M307-12
pubmed: 18314571
J Gerontol A Biol Sci Med Sci. 2013 Mar;68(3):331-7
pubmed: 22972940
Ann Intern Med. 2001 Dec 18;135(12):1038-46
pubmed: 11747382
BMC Geriatr. 2017 May 16;17(1):110
pubmed: 28511639
J Gerontol A Biol Sci Med Sci. 2014 Mar;69(3):338-45
pubmed: 23902933
J Stroke Cerebrovasc Dis. 2018 Sep;27(9):2436-2444
pubmed: 29857930
J Am Geriatr Soc. 2013 Apr;61(4):551-7
pubmed: 23527951

Auteurs

Ichiro Murayama (I)

Department of Occupational Therapy, Heisei Rehabilitation College, 2-26, Tsutonishiguchi, Nishinomiya, Hyogo, 663-8231, Japan.

Tsuyoshi Asai (T)

Department of Physical Therapy, Faculty of Rehabilitation, Kobe Gakuin University, 518 Ikawadanicho, Arise, Nishi-ku, Kobe, Hyogo, 651-2180, Japan. asai@reha.kobegakuin.ac.jp.

Shogo Misu (S)

Department of Physical Therapy, Faculty of Nursing and Rehabilitation, Konan Women's University, 6-2-13, Morikita-machi, Higashinada-ku, Kobe, Hyogo, 658-0001, Japan.
Department of Community Health Sciences, Kobe University Graduate School of Health Sciences, 7-10-2, Tomogaoka, Suma-ku, Kobe, Hyogo, 654-0142, Japan.

Masaya Yamauchi (M)

Higashiura Heisei Hospital, 1867, Kuruma, Awaji, Hyogo, 656-2311, Japan.

Azumi Miura (A)

Tamagawa Hospital, 5-31-1, Kokuryo, Cyohu, Tokyo, 182-0022, Japan.

Takeshi Ikemura (T)

Hakuai Memorial Hospital, 9, Soden, Katsura, Tokushima-shi, Tokushima, 770-8023, Japan.

Takahiro Takehisa (T)

Setagaya Memorial Hospital, 2-30-10, Noge, Setagaya-ku, Tokyo, 158-0092, Japan.

Yozo Takehisa (Y)

Hakuai Memorial Hospital, 9, Soden, Katsura, Tokushima-shi, Tokushima, 770-8023, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH